Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pearce

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Osteoarthritis and Cartilage|July 17, 2012
Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trialK Gooch, D A Marshall, P D Faris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
A red meat-derived glycan promotes inflammation and cancer progressionAnnie N Samraj, Oliver M T Pearce, Heinz Läubli, et al.
The Journal of Biological Chemistry|June 14, 2012
Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of α2-8-linked N-glycolylneuraminic acid to enzymatic cleavageLeela R L Davies, Oliver M T Pearce, Matthew B Tessier, et al.
Iscience|June 30, 2021
A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasionBeatrice Malacrida, Sam Nichols, Eleni Maniati, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2014
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerHeinz Läubli, Oliver M T Pearce, Flavio Schwarz, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
Advanced Healthcare Materials|March 12, 2024
A Self-Assembled 3D Model Demonstrates How Stiffness Educates Tumor Cell Phenotypes and Therapy Resistance in Pancreatic CancerYing Liu, Babatunde O Okesola, David Osuna de la Peña, et al.
Cancer Research|September 25, 2021
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian CancerLaura S M Lecker, Chiara Berlato, Eleni Maniati, et al.
Elife|April 8, 2015
Siglec receptors impact mammalian lifespan by modulating oxidative stressFlavio Schwarz, Oliver M T Pearce, Xiaoxia Wang, et al.
Cell Reports|January 16, 2020
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to TreatmentEleni Maniati, Chiara Berlato, Ganga Gopinathan, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Osteoarthritis and Cartilage|July 17, 2012
Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trialK Gooch, D A Marshall, P D Faris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
A red meat-derived glycan promotes inflammation and cancer progressionAnnie N Samraj, Oliver M T Pearce, Heinz Läubli, et al.
The Journal of Biological Chemistry|June 14, 2012
Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of α2-8-linked N-glycolylneuraminic acid to enzymatic cleavageLeela R L Davies, Oliver M T Pearce, Matthew B Tessier, et al.
Iscience|June 30, 2021
A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasionBeatrice Malacrida, Sam Nichols, Eleni Maniati, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2014
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerHeinz Läubli, Oliver M T Pearce, Flavio Schwarz, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
Advanced Healthcare Materials|March 12, 2024
A Self-Assembled 3D Model Demonstrates How Stiffness Educates Tumor Cell Phenotypes and Therapy Resistance in Pancreatic CancerYing Liu, Babatunde O Okesola, David Osuna de la Peña, et al.
Cancer Research|September 25, 2021
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian CancerLaura S M Lecker, Chiara Berlato, Eleni Maniati, et al.
Elife|April 8, 2015
Siglec receptors impact mammalian lifespan by modulating oxidative stressFlavio Schwarz, Oliver M T Pearce, Xiaoxia Wang, et al.
Cell Reports|January 16, 2020
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to TreatmentEleni Maniati, Chiara Berlato, Ganga Gopinathan, et al.
Pageof 14